BDBM362839 (R)-(4-fluorophenyl)(8- methyl-3-(5-methylfuran-2- yl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl)methanone::US9840508, Compound 1
SMILES: C[C@H]1N(CCn2c1nnc2-c1ccc(C)o1)C(=O)c1ccc(F)cc1
InChI Key: InChIKey=QNQLAOGIKKMCID-GFCCVEGCSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM362839 ((R)-(4-fluorophenyl)(8- methyl-3-(5-methylfuran-2-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 48 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
OGED SA US Patent | Assay Description The ability of compounds of the invention to inhibit the binding of the NK-3 receptor selective antagonist 3H-SB222200 was assessed by an in vitro ra... | US Patent US9840508 (2017) BindingDB Entry DOI: 10.7270/Q2SQ92P6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM362839 ((R)-(4-fluorophenyl)(8- methyl-3-(5-methylfuran-2-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 48 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
OGED SA US Patent | Assay Description The ability of compounds of the invention to inhibit the binding of the NK-3 receptor selective antagonist 3H-SB222200 was assessed by an in vitro ra... | US Patent US9840508 (2017) BindingDB Entry DOI: 10.7270/Q2SQ92P6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neurokinin 1 receptor (Homo sapiens (Human)) | BDBM362839 ((R)-(4-fluorophenyl)(8- methyl-3-(5-methylfuran-2-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | >3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
OGED SA US Patent | Assay Description The affinity of compounds of the invention for the NK-1 receptor was evaluated in CHO recombinant cells which express the human NK-1 receptor. Membra... | US Patent US9840508 (2017) BindingDB Entry DOI: 10.7270/Q2SQ92P6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neurokinin 2 receptor (Homo sapiens (Human)) | BDBM362839 ((R)-(4-fluorophenyl)(8- methyl-3-(5-methylfuran-2-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 5.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
OGED SA US Patent | Assay Description The affinity of compounds of the invention for the NK-2 receptor was evaluated in CHO recombinant cells which express the human NK-2 receptor. Membra... | US Patent US9840508 (2017) BindingDB Entry DOI: 10.7270/Q2SQ92P6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Neuromedin-K receptor (Homo sapiens (Human)) | BDBM362839 ((R)-(4-fluorophenyl)(8- methyl-3-(5-methylfuran-2-...) | Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 60 | n/a | n/a | n/a | n/a | n/a | n/a |
OGED SA US Patent | Assay Description The ability of compounds of the invention to inhibit the binding of the NK-3 receptor selective antagonist 3H-SB222200 was assessed by an in vitro ra... | US Patent US9840508 (2017) BindingDB Entry DOI: 10.7270/Q2SQ92P6 | |||||||||||
More data for this Ligand-Target Pair |